Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C48H75NO17 |
| Molecular Weight | 938.1056 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)[C@@H]1[C@@H](O)C[C@@]2(O)C[C@@H](O)C[C@@H](O)[C@H](O)CC[C@@H](O)C[C@@H](O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C\[C@@H](C[C@@H]1O2)O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O
InChI
InChIKey=UAZIZEMIKKIBCA-TYVGYKFWSA-N
InChI=1S/C48H75NO17/c1-28-18-16-14-12-10-8-6-7-9-11-13-15-17-19-35(65-47-45(59)42(49)44(58)31(4)64-47)25-39-41(46(60)62-5)38(55)27-48(61,66-39)26-34(52)23-37(54)36(53)21-20-32(50)22-33(51)24-40(56)63-30(3)29(2)43(28)57/h6-19,28-39,41-45,47,50-55,57-59,61H,20-27,49H2,1-5H3/b7-6+,10-8+,11-9+,14-12+,15-13+,18-16+,19-17+/t28-,29-,30-,31+,32+,33+,34-,35-,36+,37+,38-,39-,41+,42-,43+,44+,45-,47-,48+/m0/s1
| Molecular Formula | C48H75NO17 |
| Molecular Weight | 938.1056 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 19 / 19 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Amphotericin B methyl ester (also known as metamphocin), a more soluble and less toxic formulation of amphotericin B, is a new antifungal polyene antibiotic, which was studied to treat ocular mycoses and was proposed to treat Candida endophthalmitis. The suggested mechanism of its action includes the binding of this drug with the ergosterol-containing membranes.
CNS Activity
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comparative in vitro antifungal susceptibility activity of amphotericin B versus amphotericin B methyl ester against Candida albicans ocular isolates. | 2012-12 |
|
| Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence. | 2008-10 |
|
| Comparative toxicities of amphotericin B and its monomethyl ester derivative on glial cells in culture. | 1990-07 |
|
| Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols. | 1982-02-23 |
|
| Stability studies with amphotericin B and amphotericin B methyl ester. | 1975-02 |
Sample Use Guides
8 patients with keratomycosis and 2 patients with fungal endophthalmitis: drop-like intravenous injections
Route of Administration:
Intravenous
The in vitro susceptibility of amphotericin B methyl ester (AME) was determined for C. albicans isolates recovered from endophthalmitis (N=10) and for C. albicans ATCC reference strain 90028 using the Clinical and Laboratory Standards Institute M27-A2 (NCCLS/CLSI) broth dilution method. All isolates were obtained from samples of vitreous humor of patients with suspected endophthalmitis within the last 5 years at the Bascom Palmer Eye Institute, University of Miami Miller School of Medicine (Miami, FL). The minimal inhibitory concentrations (MICs) of AME was (0.125-1 μg/mL). The MIC(90) was equal (1 μg/mL). The minimal fungicidal concentrations (MFCs) of AME was (0.125-2 μg/mL).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:57:09 GMT 2025
by
admin
on
Mon Mar 31 17:57:09 GMT 2025
|
| Record UNII |
074Z98YIW3
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
36148-89-7
Created by
admin on Mon Mar 31 17:57:09 GMT 2025 , Edited by admin on Mon Mar 31 17:57:09 GMT 2025
|
PRIMARY | |||
|
C017501
Created by
admin on Mon Mar 31 17:57:09 GMT 2025 , Edited by admin on Mon Mar 31 17:57:09 GMT 2025
|
PRIMARY | |||
|
11968030
Created by
admin on Mon Mar 31 17:57:09 GMT 2025 , Edited by admin on Mon Mar 31 17:57:09 GMT 2025
|
PRIMARY | |||
|
DTXSID701009331
Created by
admin on Mon Mar 31 17:57:09 GMT 2025 , Edited by admin on Mon Mar 31 17:57:09 GMT 2025
|
PRIMARY | |||
|
074Z98YIW3
Created by
admin on Mon Mar 31 17:57:09 GMT 2025 , Edited by admin on Mon Mar 31 17:57:09 GMT 2025
|
PRIMARY |